Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally.
Moderate growth potential and slightly overvalued.
Share Price & News
How has Allscripts Healthcare Solutions's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MDRX's share price has been volatile over the past 3 months.
7 Day Return
US Healthcare Services
1 Year Return
US Healthcare Services
Return vs Industry: MDRX underperformed the US Healthcare Services industry which returned 44.1% over the past year.
Return vs Market: MDRX underperformed the US Market which returned 16.3% over the past year.
Price Volatility Vs. Market
How volatile is Allscripts Healthcare Solutions's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 months ago | Simply Wall StShould You Worry About Allscripts Healthcare Solutions, Inc.'s (NASDAQ:MDRX) CEO Pay Cheque?
4 months ago | Simply Wall StPaul Black Is The CEO & Director of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) And They Just Spent US$252k On Shares
5 months ago | Simply Wall StIs It Time To Consider Buying Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)?
Is Allscripts Healthcare Solutions undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: MDRX ($9.25) is trading below our estimate of fair value ($10.62)
Significantly Below Fair Value: MDRX is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: MDRX is unprofitable, so we can't compare its PE Ratio to the US Healthcare Services industry average.
PE vs Market: MDRX is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate MDRX's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: MDRX is good value based on its PB Ratio (1.2x) compared to the US Healthcare Services industry average (5.9x).
How is Allscripts Healthcare Solutions forecast to perform in the next 1 to 3 years based on estimates from 19 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MDRX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).
Earnings vs Market: MDRX is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: MDRX's is expected to become profitable in the next 3 years.
Revenue vs Market: MDRX's revenue (3% per year) is forecast to grow slower than the US market (9.4% per year).
High Growth Revenue: MDRX's revenue (3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MDRX's Return on Equity is forecast to be low in 3 years time (9.2%).
How has Allscripts Healthcare Solutions performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MDRX is currently unprofitable.
Growing Profit Margin: MDRX is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: MDRX is unprofitable, and losses have increased over the past 5 years at a rate of 27.2% per year.
Accelerating Growth: Unable to compare MDRX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MDRX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (9.9%).
Return on Equity
High ROE: MDRX has a negative Return on Equity (-4.24%), as it is currently unprofitable.
How is Allscripts Healthcare Solutions's financial position?
Financial Position Analysis
Short Term Liabilities: MDRX's short term assets ($869.8M) do not cover its short term liabilities ($1.1B).
Long Term Liabilities: MDRX's short term assets ($869.8M) exceed its long term liabilities ($834.6M).
Debt to Equity History and Analysis
Debt Level: MDRX's debt to equity ratio (83.4%) is considered high.
Reducing Debt: MDRX's debt to equity ratio has increased from 47.6% to 83.4% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MDRX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if MDRX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is Allscripts Healthcare Solutions's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MDRX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MDRX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MDRX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MDRX's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MDRX's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Paul Black (62 yo)
Mr. Paul M. Black has been the Chief Executive Officer of Allscripts Healthcare Solutions, Inc. since December 19, 2012. Mr. Black serves as an Adjunct Professor of Businss at the University of Missouri – ...
CEO Compensation Analysis
Compensation vs Market: Paul's total compensation ($USD7.51M) is above average for companies of similar size in the US market ($USD4.53M).
Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.
|CEO & Director||7.67yrs||US$7.51m||0.78% |
|President & CFO||4.83yrs||US$6.13m||0.13% |
|Executive VP & Chief Client Delivery Officer||3.75yrs||US$3.14m||0.056% |
|Senior VP of Development & CTO||0.42yr||no data||no data|
|VP & Chief Information Officer||0.58yr||no data||no data|
|Vice President of Investor Relations||2.17yrs||no data||no data|
|Senior VP & General Counsel||0.17yr||no data||0.12% |
|Senior Vice President of Corporate Development & Strategy||1.58yrs||no data||no data|
|Senior Vice President of Sales Operations||1.58yrs||no data||no data|
|Vice President of Marketing||0.42yr||no data||no data|
|Senior Vice President of Human Resources||0.17yr||no data||no data|
|Senior Vice President of Sales & Services and Acting General Manager||13.58yrs||no data||no data|
Experienced Management: MDRX's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
|CEO & Director||7.67yrs||US$7.51m||0.78% |
|Independent Director||8.58yrs||US$311.50k||0.074% |
|Independent Director||4.25yrs||US$314.00k||0.035% |
|Independent Chairman of the Board||6.42yrs||US$389.00k||0.072% |
|Independent Director||4.25yrs||US$292.53k||0.029% |
|Independent Director||3.25yrs||US$287.50k||0.021% |
|Independent Director||5.08yrs||US$317.50k||0.039% |
|Director||0.17yr||no data||no data|
Experienced Board: MDRX's board of directors are considered experienced (4.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Allscripts Healthcare Solutions, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Allscripts Healthcare Solutions, Inc.
- Ticker: MDRX
- Exchange: NasdaqGS
- Founded: 1986
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: US$1.507b
- Shares outstanding: 162.97m
- Website: https://www.allscripts.com
Number of Employees
- Allscripts Healthcare Solutions, Inc.
- 222 Merchandise Mart Plaza
- Suite 2024
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|MDRX||NasdaqGS (Nasdaq Global Select)||Yes||Common Shares||US||USD||Mar 2006|
|AL21||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Mar 2006|
Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health recor ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/08/08 23:47|
|End of Day Share Price||2020/08/07 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.